Insulet PODD Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $761.7M+33.9% | $783.8M+31.2% | $706.3M+29.9% | $649.1M+32.9% | $569M+28.8% | ||
| $232.7M+45.5% | $215.2M+29.2% | $196.2M+17.6% | $196.9M+24.9% | $159.9M+18.5% | ||
| $529M+29.3% | $568.6M+32.0% | $510.1M+35.3% | $452.2M+36.7% | $409.1M+33.3% | ||
| 69.4%-2.4pp | 72.5%+0.4pp | 72.2%+2.9pp | 69.7%+1.9pp | 71.9%+2.4pp | ||
| $89.7M+50.5% | $90.9M+50.0% | $77.2M+40.6% | $73.4M+36.2% | $59.6M+18.7% | ||
| $317.2M+21.7% | $331.4M+27.0% | $315.2M+34.6% | $257.7M+15.8% | $260.7M+30.5% | ||
| $21.3M+17.0% | —— | $16.7M-7.7% | $7.5M-55.9% | $18.2M+28.2% | ||
| $26.2M+20.7% | $24.4M+13.5% | $22M+3.3% | $22.3M+16.1% | $21.7M+15.4% | ||
| $300K-93.6% | —— | $100K— | $400K+167% | $4.7M+292% | ||
| -$400K-111% | —— | $1M+233% | $200K-95.6% | $3.8M+3,700% | ||
| $122.1M+37.5% | $146.3M+33.9% | $117.7M+33.6% | $121.1M+122% | $88.8M+56.1% | ||
| 16%+0.4pp | 18.7%+0.4pp | 16.7%+0.5pp | 18.7%+7.5pp | 15.6%+2.7pp | ||
| $14.7M+59.8% | $14.9M+73.3% | $15.6M+25.8% | $19.6M+78.2% | $9.2M-14.0% | ||
| $4.9M-52.4% | $5.7M-44.7% | $8.6M-18.1% | $10.1M+8.6% | $10.3M+9.6% | ||
| $700K+132% | $3.1M— | $12.1M+456% | $1.3M+172% | -$2.2M-214% | ||
| $0+100% | $0— | $0— | -$84.4M— | -$39.5M— | ||
| $113M+134% | $140.2M+25.9% | $122.8M+48.1% | $28.4M-44.4% | $48.2M-12.2% | ||
| $21.9M+72.4% | $38.5M— | $35.2M+552% | $5.9M+104% | $12.7M+274% | ||
| $91.1M+157% | $101.6M+0.9% | $87.6M+13.0% | $22.5M-88.1% | $35.4M-31.3% | ||
| 12%+5.7pp | 13%-3.9pp | 12.4%-1.8pp | 3.5%-35.1pp | 6.2%-5.4pp | ||
| $1.30+160% | $1.43+3.6% | $1.24+14.8% | $0.32-87.6% | $0.50-31.5% | ||
| $1.30+160% | $1.440.0% | $1.24+11.7% | $0.32-88.1% | $0.50-32.4% | ||
| 70.2M-5.3% | 71.9M-2.7% | 70.7M-4.4% | 70.7M-4.3% | 74.1M+0.5% | ||
| 70M-0.4% | 70.3M+0.4% | 70.4M+0.3% | 70.4M+0.5% | 70.3M+0.5% | ||
| $11.7M— | —— | —— | —— | —— | ||
| —— | —— | $7.8M— | -$95.4M— | -$77M— | ||
| $21.3M+17.0% | —— | $16.7M-8.2% | $7.5M-55.9% | $18.2M+28.2% | ||
| $200K0.0% | —— | $16.7M-8.2% | $7.5M-55.9% | $200K-98.6% | ||
| $700K-72.0% | $800K-57.9% | $800K-50.0% | $2.1M+16.7% | $2.5M+25.0% | ||
| 764K+36.4% | —— | 543K-24.8% | 2.4M+221% | 560K-16.7% | ||
| $10.1M+189% | —— | —— | $1M-82.1% | $3.5M-50.0% | ||
| $11.5M+51.3% | —— | $8.4M+21.7% | $7.9M+21.5% | $7.6M+24.6% | ||
| $6.3M+23.5% | —— | $5.9M+28.3% | $5.5M+25.0% | $5.1M+21.4% | ||
| -$235.7M-171% | —— | -$364.1M-546% | —— | $329.7M+601% | ||
| $84.2M+97.7% | —— | $84.3M-17.0% | $43.9M-76.2% | $42.6M-0.9% | ||
| $6.4M+14.3% | —— | $4.1M+57.7% | $500K-87.5% | $5.6M+80.6% | ||
| $7M+133% | $19.5M— | $35.7M+2,331% | $4M— | $3M— | ||
| -$1.9M-150% | —— | —— | $8.9M+1,089% | $3.8M+252% | ||
| $0.19-26.5% | —— | —— | —— | $0.26— | ||
| $71.4M+95.6% | $23.6M— | —— | $36.1M+3,911% | $36.5M-34.2% | ||
| -$69.3M-42.6% | —— | —— | —— | -$48.6M— | ||
| $11.5M+74.2% | $5.9M— | —— | —— | $6.6M-77.7% | ||
| -$7.6M-159% | $26.2M+414% | $23.9M+2,073% | $18.8M+22.9% | $12.8M+3,100% | ||
| 0-100% | —— | 0-100% | 0-100% | 3.5M-1.4% | ||
| $0-100% | —— | $0-100% | $0-100% | $1.7M-34.6% | ||
| —— | —— | —— | $59.4M— | —— | ||
| -$319.9M-215% | -$72.5M-249% | -$457M-23,953% | -$343.5M— | $277.7M+2,070% | ||
| -$27.7M-77.6% | -$152.8M-125% | -$31M-5.8% | -$23.3M+6.4% | -$15.6M+35.0% | ||
| $113.8M+78.4% | $183.3M+24.3% | $125.7M+16.1% | $196.5M+126% | $63.8M-27.2% | ||
| 10.0% | —— | —— | —— | 1— | ||
| 10.0% | —— | —— | —— | 1— | ||
| -$11.2M-722% | —— | -$8.3M-148% | $16.3M+255% | $1.8M+112% | ||
| -$6.6M-164% | —— | -$3.3M-111% | $22.3M+1,958% | $10.3M+256% | ||
| $0— | —— | $0— | $0— | $0— | ||
| -$300K+90.3% | —— | $100K+102% | -$900K+67.9% | -$3.1M-63.2% | ||
| -$6.9M-196% | —— | -$3.2M-113% | $21.4M+649% | $7.2M+185% | ||
| $700K+132% | $3.1M— | $12.1M+456% | $1.3M+172% | -$2.2M-214% | ||
| -$400K-111% | $2M— | $1M+233% | $200K-95.6% | $3.8M+3,700% | ||
| $300M— | $0— | $29.5M— | $30.1M— | $0— | ||
| $3.5M+2.9% | —— | $5.5M+129% | $4.6M+91.7% | $3.4M+78.9% | ||
| $15.7M-25.9% | $800K+33.3% | $2.2M+144% | $1.7M+54.5% | $21.2M+324% | ||
| $24.3M+97.6% | $135.1M+152% | $25.6M-4.1% | $18.6M-17.3% | $12.3M-44.3% | ||
| $0-100% | —— | —— | —— | $440.7M— | ||
| $0-100% | —— | $88.9M— | $52.6M— | $23.1M— | ||
| $400K-84.0% | $1.8M+260% | $4.6M+475% | $10.1M+818% | $2.5M-56.9% | ||
| $6.2M+14.8% | —— | $6.5M+18.2% | $5.8M+16.0% | $5.4M+20.0% | ||
| $14.2M+86.8% | —— | $6.1M-10.3% | $6.8M+19.3% | $7.6M+38.2% | ||
| $300K-93.6% | —— | $100K— | $400K+167% | $4.7M+292% | ||
| $4.2M-20.8% | —— | $5.1M-26.1% | $5.1M-22.7% | $5.3M-19.7% | ||
| $0-100% | $0— | $510.7M— | $377.6M— | $163.9M— | ||
| $4.5M-15.1% | —— | —— | —— | $5.3M— | ||
| $0-100% | —— | $14.2M+57.8% | $19.2M+134% | $13.4M— | ||
| -$15.7M+25.9% | —— | -$2.3M-156% | -$1.6M-60.0% | -$21.2M-324% | ||
| $21.3M+17.0% | $20.3M+1.5% | $16.7M-7.7% | $7.5M-55.9% | $18.2M+28.2% | ||
| $400K-84.0% | —— | $4.6M+557% | $10.1M+818% | $2.5M-56.9% | ||
| $0— | —— | $0— | $0— | $0— | ||
| 1.3M— | —— | 91K— | 93K— | —— | ||
| $302.7M— | —— | $29.6M— | $30.1M— | —— | ||
| $122.1M+37.5% | $146.3M+33.9% | $117.7M+33.6% | $121.1M+122% | $88.8M+56.1% | ||
| $148.3M+34.2% | $170.7M+30.5% | $139.7M+27.7% | $143.4M+94.6% | $110.5M+46.0% | ||
| $148.3M+34.2% | $170.7M+30.5% | $139.7M+27.7% | $143.4M+94.6% | $110.5M+46.0% | ||
| 19.5%0.0pp | 21.8%-0.1pp | 19.8%-0.3pp | 22.1%+7.0pp | 19.4%+2.3pp | ||
| $122.1M+37.5% | $146.3M+33.9% | $117.7M+33.6% | $121.1M+122% | $88.8M+56.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Insulet's revenue?
- Insulet (PODD) generated $2.9B in revenue over the trailing twelve months, up 31.9% year over year.
- Is Insulet profitable?
- Insulet reported $302.8M in net income over the trailing twelve months, a 10.4% net margin.
- What are Insulet's profit margins?
- Gross margin is 71.0% and operating margin is 17.5%, with a 10.4% net margin.
- What is Insulet's earnings per share?
- Insulet's diluted EPS over the trailing twelve months is $4.29.
- Where does Insulet's income statement data come from?
- Every line is extracted from Insulet's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
